Tinjauan atas Terapi Insulin

Penulis

  • Johan Indra Lukito Medical Department, PT. Kalbe Farma Tbk. Jakarta, Indonesia

DOI:

https://doi.org/10.55175/cdk.v47i7.600

Kata Kunci:

Diabetes, insulin

Abstrak

Tujuan terapi insulin adalah meniru pola sekresi insulin endogen individu normal. Berbagai jenis insulin dapat dibagi menjadi 3 kelompok utama, yaitu: insulin kerja cepat/pendek, insulin kerja menengah, dan insulin kerja panjang. Pemilihan regimen insulin disesuaikan dengan berbagai kondisi dan kebutuhan.

The goal of insulin therapy is to mimic the pattern of normal endogenous insulin secretion. Various types of insulin can be divided into 3 main groups: fast/short-acting insulin, intermediate-acting insulin, and long-acting insulin. The choice of insulin regimen is adapted to various conditions and needs.

Unduhan

Data unduhan belum tersedia.

Referensi

PERKENI. Petunjuk praktis terapi insulin pada pasien diabetes melitus tipe 2 di Indonesia. Jakarta: PERKENI; 2011.

PERKENI. Konsensus pengelolaan dan pencegahan diabetes melitus tipe 2 di Indonesia. Jakarta: PERKENI; 2011.

Diabetes Education Online [Internet]. 2019 [cited 2019 July 1]. Available from: https://dtc.ucsf.edu/

Sindoni A. Protamine insulin versus ordinary insulin. JAMA. 1937;108(16):1320-7. Available from: https://jamanetwork.com/journals/jama/article-abstract/276728

Insulin regimens and therapies [Internet]. 2019 [cited 2019 July 1) Available from: https://www.diabetes.co.uk/insulin/insulin-regimens.html

Melo KFS, Bahia LR, Pasinato B, Porfirio GJM, Martimbianco AL, Riera R, et al. Short-acting insulin analogues versus regular human insulin on postprandial glucose and hypoglycemia in type 1 diabetes mellitus: A systematic review and meta-analysis. Diabetol Metab Syndr. 2019; 11: 2.

Nabrdalik K, Kwiendacz H, Sawczyn T, Tomasik A, Kukla M, Masierek M, et al. Efficacy, safety, and quality of treatment satisfaction of premixed human and analogue insulin regimens in a large cohort of type 2 diabetic patients: PROGENS BENEFIT Observational Study. Int J Endocrinol. 2018;2018:6536178.

Laranjeira FO, de Andrade KRC, Figueiredo ACMG, Silva EN, Pereira MG. Long-acting insulin analogues for type 1 diabetes: An overview of systematic reviews and meta-analysis of randomized controlled trials. PLoS One. 2018;13(4):e0194801.

Ye X, Xin Q, Jiang X, Sun L. Comparison of effectiveness of premixed insulin with long-acting insulin in diabetes: Evidence from real-world cohort studies—systematic review and meta-analyses. Int J Diabetes Dev C. 2018;38(9):1-9.

Racsa PN, Meah Y, Ellis JJ, Saverno KR. Comparative effectiveness of rapid-acting insulins in adults with diabetes. J Manag Care Spec Pharm. 2017;23(3):291-8.

Blum AK. Insulin use in pregnancy: An update. Diabetes Spectr 2016; 29(2): 92-7.

Nørgaard K, Sukumar N, Rafnsson SB, Saravanan P. Efficacy and safety of rapid-acting insulin analogs in special populations with type 1 diabetes or gestational diabetes: Systematic review and meta-analysis. Diabetes Ther. 2018;9(3):891-917.

Philotheou A, Arslanian S, Blatniczky L, Peterkova V, Souhami E, Danne T. Comparable efficacy and safety of insulin glulisine and insulin lispro when given as part of a Basal-bolus insulin regimen in a 26-week trial in pediatric patients with type 1 diabetes. Diabetes Technol Ther. 2011;13(3):327-34.

Diterbitkan

2020-09-01

Cara Mengutip

Lukito, J. I. (2020). Tinjauan atas Terapi Insulin. Cermin Dunia Kedokteran, 47(7), 525–529. https://doi.org/10.55175/cdk.v47i7.600

Terbitan

Bagian

Articles